An Official Website of the United States Government
Company Information:
Name:
ALLVIVO VASCULAR, INC.
Address:
20914 BAKE PKY
LAKE FOREST, CA 92630-
LAKE FOREST, CA 92630-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
SBIR/STTR Phase I:Surface Modification to Direct Cell Behavior
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
Jennifer Neff
Award Amount:
$97,543.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project will develop a surface coating technology that will be used to create improved materials for regulating cell behavior for research, tissue engineering and cell therapy applications. For these applications, advanced materials are needed… More
Peptide Based Antibacterial Coating
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jennifer A. Neff
Award Amount:
$99,547.00
Abstract:
DESCRIPTION (provided by applicant): The long-term objective of this SBIR Phase I project is to develop antibacterial coatings for medical devices. The use of traditional antimicrobials on devices poses a substantial risk for developing drug resistant bacteria. The objective is to develop coatings… More
Peptide Based Antibacterial Coating
Award Year / Program / Phase:
2007 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Jennifer A. Neff
Award Amount:
$821,425.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this work is to develop dual function antibacterial coatings that prevent biofilm formation and thrombus. A key feature of this technology is that it will prevent biofilm formation without an associated
risk of creating antibiotic resistant… More
Dual Function Catheter to Prevent Thrombus and Infection
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Jennifer A. Neff – 949-716-6478
Award Amount:
$2,997,913.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this work is to complete development of a novel antibacterial, acute hemodialysis catheter and conduct the preclinical testing required for FDA approval. This product will address 3 major unmet needs for intravenous catheters by: (1) providing… More